| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
|
Kim, Jin Won
|
|
2015
|
75 |
6 |
p. 1175-1182
|
article
|
| 2 |
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)
|
Hata, Akito
|
|
2015
|
75 |
6 |
p. 1267-1272
|
article
|
| 3 |
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test
|
Choi, Moon Ki
|
|
2015
|
75 |
6 |
p. 1229-1236
|
article
|
| 4 |
A phase I study of resminostat in Japanese patients with advanced solid tumors
|
Kitazono, Satoru
|
|
2015
|
75 |
6 |
p. 1155-1161
|
article
|
| 5 |
Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury
|
Nakano, Kazuhiko
|
|
2015
|
75 |
6 |
p. 1191-1197
|
article
|
| 6 |
Cisplatin resistance in human cervical, ovarian and lung cancer cells
|
Chen, Jianli
|
|
2015
|
75 |
6 |
p. 1217-1227
|
article
|
| 7 |
Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe
|
Yang, Bing-Bing
|
|
2015
|
75 |
6 |
p. 1199-1206
|
article
|
| 8 |
Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis
|
Zhao, Rongbao
|
|
2015
|
75 |
6 |
p. 1163-1173
|
article
|
| 9 |
DNA intercalative 4-butylaminopyrimido[4′,5′:4,5]thieno(2,3-b)quinoline induces cell cycle arrest and apoptosis in leukemia cells
|
RohitKumar, Heggodu G.
|
|
2015
|
75 |
6 |
p. 1121-1133
|
article
|
| 10 |
Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines
|
Karaca, Burcak
|
|
2015
|
75 |
6 |
p. 1273-1280
|
article
|
| 11 |
Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors
|
Castellano, Daniel
|
|
2014
|
75 |
6 |
p. 1099-1114
|
article
|
| 12 |
Functional polymorphisms of ITGB1 are associated with clinical outcome of Chinese patients with resected colorectal cancer
|
Zhou, Feng
|
|
2015
|
75 |
6 |
p. 1207-1215
|
article
|
| 13 |
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs
|
Kawamura, Takahisa
|
|
2015
|
75 |
6 |
p. 1261-1266
|
article
|
| 14 |
Inhibition of SN-38 glucuronidation by gefitinib and its metabolite
|
Li, Wei
|
|
2015
|
75 |
6 |
p. 1253-1260
|
article
|
| 15 |
Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination
|
Tedeschi, Philip M.
|
|
2015
|
75 |
6 |
p. 1247-1252
|
article
|
| 16 |
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor
|
D’Alessandro, Rosalba
|
|
2015
|
75 |
6 |
p. 1237-1245
|
article
|
| 17 |
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients
|
Koumarianou, Anna
|
|
2015
|
75 |
6 |
p. 1289-1301
|
article
|
| 18 |
Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites
|
Darwish, Mona
|
|
2015
|
75 |
6 |
p. 1143-1154
|
article
|
| 19 |
Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial
|
Kato, Takehiro
|
|
2015
|
75 |
6 |
p. 1281-1288
|
article
|
| 20 |
Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer
|
Kordes, S.
|
|
2015
|
75 |
6 |
p. 1135-1141
|
article
|
| 21 |
Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial
|
Yamamoto, D.
|
|
2015
|
75 |
6 |
p. 1183-1189
|
article
|
| 22 |
Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients
|
Aoyama, Toru
|
|
2015
|
75 |
6 |
p. 1115-1120
|
article
|
| 23 |
Targeting the EWS–FLI1 transcription factor in Ewing sarcoma
|
Tancredi, R.
|
|
2015
|
75 |
6 |
p. 1317-1320
|
article
|
| 24 |
The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1
|
Chang, Ling-Chu
|
|
2015
|
75 |
6 |
p. 1303-1315
|
article
|
Journal description